Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Detection method for non-small cell lung cancer peripheral blood circulating tumor cell PDL1 gene

A technology for non-small cell lung cancer and peripheral blood circulation, applied in measuring devices, instruments, scientific instruments, etc., can solve problems such as inability to detect PDL1 in patients, achieve the effects of reducing detection procedures and costs, improving detection efficiency, and good clinical promotion value

Active Publication Date: 2016-12-07
上海立闻生物科技有限公司
View PDF6 Cites 33 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The present invention separates and detects the circulating tumor cells of the patient, thereby realizing the evaluation of the expression of the patient's PDL1, and solving the problem that the patient's PDL1 cannot be detected due to the inability to obtain tumor pathological tissue samples. All patients who obtain tumor pathological tissue through surgery and other means benefit

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection method for non-small cell lung cancer peripheral blood circulating tumor cell PDL1 gene
  • Detection method for non-small cell lung cancer peripheral blood circulating tumor cell PDL1 gene
  • Detection method for non-small cell lung cancer peripheral blood circulating tumor cell PDL1 gene

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0055] The present invention will be further described below in conjunction with the accompanying drawings and embodiments.

[0056] In the present invention, the term HE staining hematoxylin-eosin staining (hematoxylin-eosin staining) is a commonly used staining method in paraffin section technique. Hematoxylin staining solution is alkaline, which mainly makes the chromatin in the nucleus and ribosomes in the cytoplasm purple-blue; eosin is an acidic dye, which mainly makes the components in the cytoplasm and extracellular matrix red.

[0057] 1. Separation and acquisition of circulating tumor cells from the peripheral blood of patients with non-small cell lung cancer by using a membrane filtration device:

[0058] Obtaining blood samples from patients with non-small cell lung cancer:

[0059] The peripheral blood of 5 patients diagnosed with non-small cell lung cancer was collected, and 5ml of peripheral blood was collected from each case. At the same time, 5 ml of blood s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a detection method for a non-small cell lung cancer peripheral blood circulating tumor cell PDL1 gene. The method comprises the steps that a, a peripheral blood sample from a non-small cell lung cancer is subjected to membrane filtration, and peripheral blood circulating tumor cells are obtained; b, a filter membrane obtained in the step a is fixed; c, the filter membrane obtained in the step b is detected in situ to determine the PDL1 expression condition; if PDL1 monochrome positive cells are detected in the step c, and HE dyeing is further used for identifying circulating tumor cells for the filter membrane.

Description

technical field [0001] The invention relates to a method for detecting a new target protein of peripheral blood circulating tumor cells, in particular to a method for detecting the PDL1 gene of peripheral blood tumor cells of patients with non-small cell lung cancer. Background technique [0002] Programmed cell death 1 ligand 1 (PDL1), also known as surface antigen differentiation cluster 274 (cluster of differentiation 274, CD274) or B7 homolog (B7 homolog 1, B7-H1), is A protein in humans, encoded by the CD274 gene. Non-small cell lung cancer induces the formation of an immunosuppressive tumor microenvironment by expressing PDL1, evading the body's anti-tumor immune response, and preventing tumor cells from being monitored and eliminated by the body's immune system. Studies have shown that there is a significant correlation between the expression level of PDL1 / PD1 in non-small cell lung cancer tissues and the clinicopathological factors and prognosis of patients. PDL1 / P...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/574G01N33/533
CPCG01N33/533G01N33/57496
Inventor 闻丹忆
Owner 上海立闻生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com